Table 1.

Patients’ characteristics before EBRT

Patient	Age	PSA level, ng/mL			Mean time to reach PSA nadir, months	Clinical stage	D’Amico risk category		Neoadjuvant ADT	HIFU-related toxicity
		At diagnosis	Nadir after HIFU	Before EBRT			Low	Inter-mediate		Urinary incontinence	Gastro-intestinal
#1	60	6.16	2.51	2.51	12	T1	Yes		No	No	No
#2	68	14.5	14	14.8	3	T1		Yes	No	No	No
#3	66	4.57	0.73	2.5	3	T1	Yes		No	No	No
#4	79	9.96	3.5	4.27	3	T1	Yes		No	No	No
#5	73	4.23	5.6	6.7	3	T1	Yes		No	No	No
#6	67	16	1.3	5.6	1	T1		Yes	No	No	No

HIFU: high-intensity focused ultrasound; PSA: prostate-specific antigen; EBRT: external beam radiotherapy; ADT, Androgen deprivation therapy.